🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/01/2009 | 8,16 | 8,42 | 7,75 | 7,94 | -1,85% | 8,26% | 162.892 |
| 29/01/2009 | 8,23 | 8,42 | 8,05 | 8,08 | -3,14% | 4,55% | 215.497 |
| 28/01/2009 | 7,86 | 8,50 | 7,82 | 8,35 | +8,78% | 8,57% | 250.896 |
| 27/01/2009 | 7,71 | 8,05 | 7,60 | 7,67 | -0,49% | 5,82% | 56.399 |
| 26/01/2009 | 7,52 | 7,97 | 7,45 | 7,71 | +3,00% | 6,97% | 54.529 |
| 23/01/2009 | 7,41 | 8,05 | 7,37 | 7,49 | +0,00% | 9,09% | 97.035 |
| 22/01/2009 | 8,01 | 8,08 | 7,37 | 7,49 | -4,76% | 8,88% | 67.433 |
| 21/01/2009 | 7,60 | 8,05 | 6,96 | 7,86 | +5,53% | 14,29% | 165.723 |
| 20/01/2009 | 7,41 | 8,23 | 7,15 | 7,45 | -13,48% | 14,65% | 170.212 |
| 16/01/2009 | 9,25 | 9,25 | 7,97 | 8,61 | -5,74% | 13,76% | 72.990 |
| 15/01/2009 | 7,60 | 9,36 | 7,49 | 9,13 | +20,20% | 24,63% | 144.163 |
| 14/01/2009 | 7,60 | 8,05 | 7,60 | 7,60 | -2,40% | 5,91% | 91.050 |
| 13/01/2009 | 7,49 | 8,31 | 7,49 | 7,79 | +4,00% | 11,00% | 68.956 |
| 12/01/2009 | 8,83 | 8,91 | 7,49 | 7,49 | -14,89% | 16,10% | 204.623 |
| 09/01/2009 | 10,18 | 10,18 | 8,72 | 8,80 | -13,28% | 14,34% | 157.174 |
| 08/01/2009 | 9,39 | 10,44 | 9,39 | 10,14 | +7,54% | 11,15% | 104.516 |
| 07/01/2009 | 9,96 | 10,07 | 9,25 | 9,43 | -7,35% | 8,27% | 114.962 |
| 06/01/2009 | 10,41 | 10,63 | 9,77 | 10,18 | -1,09% | 8,27% | 74.005 |
| 05/01/2009 | 10,14 | 10,29 | 9,36 | 10,29 | +1,85% | 9,22% | 67.860 |
| 02/01/2009 | 10,26 | 10,85 | 9,88 | 10,11 | -1,46% | 9,49% | 113.279 |
| 31/12/2008 | 10,11 | 10,93 | 9,39 | 10,26 | +1,86% | 15,18% | 327.867 |
| 30/12/2008 | 9,92 | 10,14 | 9,28 | 10,07 | +1,89% | 8,68% | 135.213 |
| 29/12/2008 | 9,92 | 9,92 | 8,50 | 9,88 | -0,38% | 14,34% | 137.751 |
| 26/12/2008 | 9,88 | 9,92 | 9,17 | 9,92 | +1,15% | 7,58% | 36.308 |
| 24/12/2008 | 9,92 | 10,07 | 9,25 | 9,81 | +1,55% | 8,30% | 345.901 |
| 23/12/2008 | 9,43 | 9,88 | 9,28 | 9,66 | +3,61% | 6,35% | 66.124 |
| 22/12/2008 | 8,46 | 10,26 | 8,46 | 9,32 | -5,68% | 21,24% | 64.628 |
| 19/12/2008 | 8,61 | 10,29 | 8,61 | 9,88 | +6,88% | 19,56% | 205.371 |
| 18/12/2008 | 10,67 | 11,00 | 8,68 | 9,25 | -2,76% | 21,75% | 157.922 |
| 17/12/2008 | 9,32 | 9,54 | 9,21 | 9,51 | +0,40% | 3,61% | 63.773 |